| Gene symbol | BIRC5 | Synonyms | API4, EPR-1 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | baculoviral IAP repeat containing 5 | ||||
| Gene symbol | TERT | Synonyms | CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5p15.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | telomerase reverse transcriptase | ||||
| Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | WT1 transcription factor | ||||
| GTO ID | GTC2752 |
| Trial ID | NCT05000801 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | WT1|TERT|BIRC5 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | DC Vaccine |
| Recruitment status | Recruiting |
| Title | Safety and Feasibility Study of Dendritic Cell (DC) Vaccination Expressing WT1/hTERT/Survivin in AML Patients With Minimal Residual Disease (MRD) |
| Year | 2021 |
| Country | China |
| Company sponsor | Affiliated Hospital to Academy of Military Medical Sciences |
| Other ID(s) | 307-DC-1911 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||